Matsuoka, Katsuyoshi
Kobayashi, Taku
Ueno, Fumiaki
Matsui, Toshiyuki
Hirai, Fumihito
Inoue, Nagamu
Kato, Jun
Kobayashi, Kenji
Kobayashi, Kiyonori
Koganei, Kazutaka
Kunisaki, Reiko
Motoya, Satoshi
Nagahori, Masakazu
Nakase, Hiroshi
Omata, Fumio
Saruta, Masayuki
Watanabe, Toshiaki
Tanaka, Toshiaki
Kanai, Takanori
Noguchi, Yoshinori
Takahashi, Ken-ichi
Watanabe, Kenji
Hibi, Toshifumi
Suzuki, Yasuo
Watanabe, Mamoru
Sugano, Kentaro
Shimosegawa, Tooru
Article History
Received: 22 January 2018
Accepted: 23 January 2018
First Online: 10 February 2018
Compliance with ethical standards
:
: Any financial relationship with enterprises, businesses, or academic institutions in the subject matter or materials discussed in the manuscript are listed as follows: (1) those from which the authors have received individually any income, honoraria or any other types of remuneration; Abbvie Inc., EA Pharma Co., Ltd., Eisai Co., Ltd., IGAKU-SHOIN Ltd, Yakult Honsha Co., Ltd, Mitsubishi Tanabe Pharma Corporation; and (2) those from which the academic institutions of the authors received support (commercial/academic cooperation); Asahi Kasei Medical Co., Ltd., Astellas Pharma Inc., AstraZeneca K.K., Abbvie Inc., EA Pharma Co., Ltd., Eisai Co., Ltd., Eidia Co., Ltd., Otsuka Pharmaceutical Co., Ltd., Kyorin Pharmaceutical Co., Ltd., GlaxoSmithKline K.K., JIMRO Co., Ltd., Zeria Pharmaceutical Co., Ltd., Daiichi Sankyo Co., Ltd., Taiho Pharmaceutical Co., Ltd., Takeda Pharmaceutical Company Limited., Mitsubishi Tanabe Pharma Corporation, Chugai Pharmaceutical Co., Ltd., Biofermin Seiyaku Co., Ltd., Pfizer Inc. Bristol-Myers Squibb Company, Merck Serono Co., Ltd. Mochida Pharmaceutical Co., Ltd. Yakult Honsha Co., Ltd., Janssen Pharmaceutical K.K.